Shares of Evoke plc (LON:EVOK - Get Free Report) fell 18.9% during mid-day trading on Wednesday . The stock traded as low as GBX 57.50 ($0.74) and last traded at GBX 57.90 ($0.75). 6,787,128 shares changed hands during trading, an increase of 234% from the average session volume of 2,033,852 shares. The stock had previously closed at GBX 71.40 ($0.92).
Wall Street Analyst Weigh In
A number of research analysts have recently issued reports on EVOK shares. Berenberg Bank cut their target price on shares of Evoke from GBX 130 ($1.68) to GBX 90 ($1.16) and set a "buy" rating for the company in a research note on Wednesday, December 4th. Jefferies Financial Group reiterated a "buy" rating and issued a GBX 140 ($1.81) price objective on shares of Evoke in a research report on Monday, December 16th.
View Our Latest Stock Analysis on Evoke
Evoke Trading Down 1.1 %
The stock has a market cap of £224.78 million, a P/E ratio of -1.26 and a beta of 0.84. The business's fifty day simple moving average is GBX 68.88 and its 200 day simple moving average is GBX 63.49.
Evoke (LON:EVOK - Get Free Report) last released its quarterly earnings results on Wednesday, March 26th. The company reported GBX (6.40) (($0.08)) EPS for the quarter. Evoke had a negative net margin of 8.50% and a negative return on equity of 517.98%. On average, analysts predict that Evoke plc will post 12.7648305 earnings per share for the current fiscal year.
Insider Activity
In other Evoke news, insider Andrea Gisle Joosen bought 14,572 shares of Evoke stock in a transaction dated Tuesday, January 28th. The shares were bought at an average price of GBX 70 ($0.91) per share, with a total value of £10,200.40 ($13,202.69). Insiders own 27.00% of the company's stock.
About Evoke
(
Get Free Report)
Recommended Stories
Before you consider Evoke, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Evoke wasn't on the list.
While Evoke currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.